Please wait while the formulary information is being retrieved.
VIRAZOLE (RIBAVIRIN)
- Respiratory syncytial virus infection
6 gram solution for inhalation
- Dosage information is not available
6 gram solution for inhalation
- Dosage information is not available
- didanosine
- Videx 2 Gram Pediatric
- Videx 4 Gram Pediatric
- Videx Ec
Contraindicated
- abacavir-lamivudine-zidovudine
- Combivir
- lamivudine-zidovudine
- Retrovir
- stavudine
- Trizivir
- Zerit
- zidovudine
Severe
Moderate
- Azasan
- azathioprine
- azathioprine sodium
- Imuran
- mercaptopurine
- Purinethol
- Pregnancy
Contraindicated
- None
Severe
Moderate
- Anemia
- Asthma
- Chronic obstructive pulmonary disease
VIRAZOLE (RIBAVIRIN)
- Respiratory syncytial virus infection
- Anemia
- Dyspnea
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Apnea
- Bradycardia
- Bronchospastic pulmonary disease
- Cardiac arrest
- Cyanosis
- Hypotension
- Hypoventilation
- Pneumonia
- Pneumothorax
- Pulmonary edema
Less Severe
- Conjunctivitis
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Ribavirin
- Severity Level:
1
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ribavirin
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Caution is advised when using this medication in people who are using a certain breathing device (ventilator). Read and follow the manufacturer's directions for use and care of the ventilator. Follow all directions from the manufacturer to prevent particle buildup in the device.<br /><br />Doing so will help the device work properly and may prevent serious side effects (e.g., air pressure buildup inside the lungs). Infrequently, sudden worsening of breathing problems may occur, especially when this medication is first started. If this occurs, treatment should be stopped. If you and the doctor decide to restart ribavirin treatment, the doctor will monitor closely to decrease the risk of side effects.
| Respiratory syncytial virus infection | |
| B97.4 | Respiratory syncytial virus as the cause of diseases classified elsewhere |
| J12.1 | Respiratory syncytial virus pneumonia |
| J20.5 | Acute bronchitis due to respiratory syncytial virus |
| J21.0 | Acute bronchiolitis due to respiratory syncytial virus |
| 0-9 | A-Z |
|---|---|
| B97.4 | Respiratory syncytial virus as the cause of diseases classified elsewhere |
| J12.1 | Respiratory syncytial virus pneumonia |
| J20.5 | Acute bronchitis due to respiratory syncytial virus |
| J21.0 | Acute bronchiolitis due to respiratory syncytial virus |
Formulary Reference Tool